Sunday, December 10, 2023

Tag: LAI

Luye

Positive results for Luye Pharma schizophrenia drug

HTP Desk - 0
Luye Pharma’s pipeline asset LY03010, a once-monthly, long-acting injectable (LAI) form of paliperidone, has achieved the primary endpoint in a pivotal trial and demonstrated...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
© 2020. All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!